ALIMP Implanet S.A.

0.1578EUR+3.82%Mkt Cap: 24.67M $P/E: —

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The compan…

Key Statistics

Company
Market Cap24.67M USD
Enterprise Value28.59M USD
Revenue (TTM)15.00M USD
Gross Profit7.49M USD
Net Income (TTM)-4.76M USD
Revenue/Share0.10 EUR
Last Price0.1578 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-6.95
EV/Revenue1.91
P/S1.58
P/B-12.67
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.15003% of range0.4425
52W High0.4425 EUR
52W Low0.1500 EUR
Profitability
Gross Margin55.27%
Oper. Margin-26.20%
EBITDA Margin-27.42%
Profit Margin-35.13%
ROE-1084.65%
ROA-23.75%
Growth
Revenue Growth22.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-640.22K USD
CapEx (TTM)1.70M USD
FCF Margin-7.65%
FCF Yield-4.65%
Net Debt4.83M USD
Net Debt/EBITDA-1.17
Balance Sheet
Debt/Equity14.66
Current Ratio0.68
Quick Ratio0.28
Book Value/Sh-0.01 EUR
Cash/Share0.0070 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateFeb 3, 2020
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.143.82M
Float49.79M
Insiders66.13%
Institutions0.00%
Technical
SMA 500.1737 (-9.2%)
SMA 2000.1974 (-20.1%)
Beta0.64
S&P 52W Chg14.58%
Avg Vol (30d)48.75K
Avg Vol (10d)54.14K
Technical Indicators
RSI (14)40.4
MACD-0.0048
MACD Signal-0.0039
MACD Hist.-0.0009
BB Upper0.1778 EUR
BB Middle0.1659 EUR
BB Lower0.1541 EUR
BB Width14.28%
ATR (14)0.0076 EUR
Vol Ratio (20d)0.27x